Antibiotic Resistance Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Drug Class (Oxazolidinones, Cephalosporins, Tetracyclines, Lipoglycopeptides, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies)

Report Code: TIPRE00011956 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Antimicrobial substances that is used to combat bacterial infection are termed as antibiotics. These are used to heal several medical conditions like stroke, sinus, urinary tract infections, ear infections, pneumonia, skin infections, and other diseases. The classification of antibiotics is based on chemical structures, activity spectrum, and action method. The capacity to withstand the infection is known as resistance to antibiotics. Worldwide, this is expected to be a key issue, leading to the full-fledged emergence of the global antibiotic resistance market.

MARKET DYNAMICS

The artificial intelligence in the healthcare diagnosis market is driven by many pharmaceutical companies are focusing to develop the antibiotic resistance drugs. However, lack of interest of investor for the research and development of antibiotics resistance therapies will also hamper the development of antibiotic resistance market. Moreover, rising number of patient pool suffering from bacterial infection is the primary factor driving the growth of antibiotic resistance market over the forecast period

MARKET SCOPE

The "Antibiotic Resistance Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of antibiotic resistance market with detailed market segmentation by drug class and distribution channel. The antibiotic resistance market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in antibiotic resistance market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The antibiotic resistance market is segmented on the basis of drug class and distribution channel. Based on drug class, the market is segmented as oxazolidinones, cephalosporins, tetracyclines, lipoglycopeptides and others. On the basis of distribution channel, the market is categorized as hospital pharmacies, retail pharmacies, drug stores and online pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the antibiotic resistance market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The antibiotic resistance market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting antibiotic resistance market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the antibiotic resistance market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the antibiotic resistance market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from antibiotic resistance market are anticipated to have lucrative growth opportunities in the future with the rising demand for antibiotic resistance in the global market. Below mentioned is the list of few companies engaged in the antibiotic resistance market.

The report also includes the profiles of key players in antibiotic resistance market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Achaogen, Inc.
  •   Basilea Pharmaceutica Ltd.
  •   Entasis Therapeutics
  •   Melinta Therapeutics
  •   PARATEK therapeutics
  •   Seres Therapeutics, Inc.
  •   Tetraphase Pharmaceuticals, Inc.
  •   Theravance Biopharma, Inc
  •   Wockhardt therapeutics


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antibiotic Resistance Market - By Drug Class
1.3.2 Antibiotic Resistance Market - By Distribution Channel
1.3.3 Antibiotic Resistance Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTIBIOTIC RESISTANCE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIBIOTIC RESISTANCE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIBIOTIC RESISTANCE MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIBIOTIC RESISTANCE - GLOBAL MARKET OVERVIEW
6.2. ANTIBIOTIC RESISTANCE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIBIOTIC RESISTANCE MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. OXAZOLIDINONES
7.3.1. Overview
7.3.2. Oxazolidinones Market Forecast and Analysis
7.4. CEPHALOSPORINS
7.4.1. Overview
7.4.2. Cephalosporins Market Forecast and Analysis
7.5. TETRACYCLINES
7.5.1. Overview
7.5.2. Tetracyclines Market Forecast and Analysis
7.6. LIPOGLYCOPEPTIDES
7.6.1. Overview
7.6.2. Lipoglycopeptides Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. ANTIBIOTIC RESISTANCE MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. DRUG STORES
8.5.1. Overview
8.5.2. Drug Stores Market Forecast and Analysis
8.6. ONLINE PHARMACIES
8.6.1. Overview
8.6.2. Online Pharmacies Market Forecast and Analysis
9. ANTIBIOTIC RESISTANCE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Antibiotic Resistance Market Overview
9.1.2 North America Antibiotic Resistance Market Forecasts and Analysis
9.1.3 North America Antibiotic Resistance Market Forecasts and Analysis - By Drug Class
9.1.4 North America Antibiotic Resistance Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Antibiotic Resistance Market Forecasts and Analysis - By Countries
9.1.5.1 United States Antibiotic Resistance Market
9.1.5.1.1 United States Antibiotic Resistance Market by Drug Class
9.1.5.1.2 United States Antibiotic Resistance Market by Distribution Channel
9.1.5.2 Canada Antibiotic Resistance Market
9.1.5.2.1 Canada Antibiotic Resistance Market by Drug Class
9.1.5.2.2 Canada Antibiotic Resistance Market by Distribution Channel
9.1.5.3 Mexico Antibiotic Resistance Market
9.1.5.3.1 Mexico Antibiotic Resistance Market by Drug Class
9.1.5.3.2 Mexico Antibiotic Resistance Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Antibiotic Resistance Market Overview
9.2.2 Europe Antibiotic Resistance Market Forecasts and Analysis
9.2.3 Europe Antibiotic Resistance Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Antibiotic Resistance Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Antibiotic Resistance Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Antibiotic Resistance Market
9.2.5.1.1 Germany Antibiotic Resistance Market by Drug Class
9.2.5.1.2 Germany Antibiotic Resistance Market by Distribution Channel
9.2.5.2 France Antibiotic Resistance Market
9.2.5.2.1 France Antibiotic Resistance Market by Drug Class
9.2.5.2.2 France Antibiotic Resistance Market by Distribution Channel
9.2.5.3 Italy Antibiotic Resistance Market
9.2.5.3.1 Italy Antibiotic Resistance Market by Drug Class
9.2.5.3.2 Italy Antibiotic Resistance Market by Distribution Channel
9.2.5.4 Spain Antibiotic Resistance Market
9.2.5.4.1 Spain Antibiotic Resistance Market by Drug Class
9.2.5.4.2 Spain Antibiotic Resistance Market by Distribution Channel
9.2.5.5 United Kingdom Antibiotic Resistance Market
9.2.5.5.1 United Kingdom Antibiotic Resistance Market by Drug Class
9.2.5.5.2 United Kingdom Antibiotic Resistance Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Antibiotic Resistance Market Overview
9.3.2 Asia-Pacific Antibiotic Resistance Market Forecasts and Analysis
9.3.3 Asia-Pacific Antibiotic Resistance Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Antibiotic Resistance Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Antibiotic Resistance Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Antibiotic Resistance Market
9.3.5.1.1 Australia Antibiotic Resistance Market by Drug Class
9.3.5.1.2 Australia Antibiotic Resistance Market by Distribution Channel
9.3.5.2 China Antibiotic Resistance Market
9.3.5.2.1 China Antibiotic Resistance Market by Drug Class
9.3.5.2.2 China Antibiotic Resistance Market by Distribution Channel
9.3.5.3 India Antibiotic Resistance Market
9.3.5.3.1 India Antibiotic Resistance Market by Drug Class
9.3.5.3.2 India Antibiotic Resistance Market by Distribution Channel
9.3.5.4 Japan Antibiotic Resistance Market
9.3.5.4.1 Japan Antibiotic Resistance Market by Drug Class
9.3.5.4.2 Japan Antibiotic Resistance Market by Distribution Channel
9.3.5.5 South Korea Antibiotic Resistance Market
9.3.5.5.1 South Korea Antibiotic Resistance Market by Drug Class
9.3.5.5.2 South Korea Antibiotic Resistance Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Antibiotic Resistance Market Overview
9.4.2 Middle East and Africa Antibiotic Resistance Market Forecasts and Analysis
9.4.3 Middle East and Africa Antibiotic Resistance Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Antibiotic Resistance Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Antibiotic Resistance Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Antibiotic Resistance Market
9.4.5.1.1 South Africa Antibiotic Resistance Market by Drug Class
9.4.5.1.2 South Africa Antibiotic Resistance Market by Distribution Channel
9.4.5.2 Saudi Arabia Antibiotic Resistance Market
9.4.5.2.1 Saudi Arabia Antibiotic Resistance Market by Drug Class
9.4.5.2.2 Saudi Arabia Antibiotic Resistance Market by Distribution Channel
9.4.5.3 U.A.E Antibiotic Resistance Market
9.4.5.3.1 U.A.E Antibiotic Resistance Market by Drug Class
9.4.5.3.2 U.A.E Antibiotic Resistance Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Antibiotic Resistance Market Overview
9.5.2 South and Central America Antibiotic Resistance Market Forecasts and Analysis
9.5.3 South and Central America Antibiotic Resistance Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Antibiotic Resistance Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Antibiotic Resistance Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Antibiotic Resistance Market
9.5.5.1.1 Brazil Antibiotic Resistance Market by Drug Class
9.5.5.1.2 Brazil Antibiotic Resistance Market by Distribution Channel
9.5.5.2 Argentina Antibiotic Resistance Market
9.5.5.2.1 Argentina Antibiotic Resistance Market by Drug Class
9.5.5.2.2 Argentina Antibiotic Resistance Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANTIBIOTIC RESISTANCE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANTIBIOTIC RESISTANCE MARKET, KEY COMPANY PROFILES
12.1. ACHAOGEN, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BASILEA PHARMACEUTICA LTD.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ENTASIS THERAPEUTICS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MELINTA THERAPEUTICS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PARATEK THERAPEUTICS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SERES THERAPEUTICS, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. TETRAPHASE PHARMACEUTICALS, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. THERAVANCE BIOPHARMA, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. WOCKHARDT THERAPEUTICS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Achaogen, Inc.
2. Basilea Pharmaceutica Ltd.
3. Entasis Therapeutics
4. Melinta Therapeutics
5. PARATEK therapeutics
6. Seres Therapeutics, Inc.
7. Tetraphase Pharmaceuticals, Inc.
8. Theravance Biopharma, Inc
9. Wockhardt therapeutics
TIPRE00011956
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking